David Colleran
2020
In 2020, David Colleran earned a total compensation of $1.7M as EVP, General Counsel and Secretary at Anika Therapeutics.
Compensation breakdown
| Bonus | $143,931 |
|---|---|
| Option Awards | $553,445 |
| Salary | $344,077 |
| Stock Awards | $645,900 |
| Other | $18,263 |
| Total | $1,705,616 |
Colleran received $645.9K in stock awards, accounting for 38% of the total pay in 2020.
Colleran also received $143.9K in bonus, $553.4K in option awards, $344.1K in salary and $18.3K in other compensation.
Rankings
In 2020, David Colleran's compensation ranked 6,270th out of 13,090 executives tracked by ExecPay. In other words, Colleran earned more than 52.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,270 out of 13,090 | 52nd |
Division Manufacturing | 2,583 out of 5,621 | 54th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 325 out of 799 | 59th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 182 out of 495 | 63rd |
Industry Surgical and Medical Instruments and Apparatus | 118 out of 313 | 62nd |
Source: SEC filing on April 30, 2021.
Colleran's colleagues
We found six more compensation records of executives who worked with David Colleran at Anika Therapeutics in 2020.
2020
Cheryl Blanchard
Anika Therapeutics
Chief Executive Officer
2020
Michael Levitz
Anika Therapeutics
Chief Financial Officer
2020
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
2020
Thomas Finnerty
Anika Therapeutics
EVP, Human Resources
2020
James Loerop
Anika Therapeutics
EVP, Business Development and Strategic Planning
2020
Joseph Darling
Anika Therapeutics